id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-E-0359-0006,FDA,FDA-2025-E-0359,Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY,Notice,Determinations,2026-02-13T05:00:00Z,2026,2,2026-02-13T05:00:00Z,2026-04-15T03:59:59Z,2026-02-13T19:43:37Z,2026-02971,1,0,09000064b91a9ff7
FDA-2025-E-0359-0005,FDA,FDA-2025-E-0359,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,,2025-12-03T17:27:47Z,,0,0,09000064b90aad95
FDA-2025-E-0359-0004,FDA,FDA-2025-E-0359,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-11-05T05:00:00Z,2025,11,2025-11-05T05:00:00Z,,2025-11-05T22:09:47Z,,0,0,09000064b90691a2
FDA-2025-E-0359-0003,FDA,FDA-2025-E-0359,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-09-26T04:00:00Z,2025,9,2025-09-26T04:00:00Z,,2025-11-05T02:21:15Z,,0,0,09000064b8fdecf0
FDA-2025-E-0359-0002,FDA,FDA-2025-E-0359,Patent Extension Application from Edward J. Baba (on behalf of The Board of Trustees of the Leland Stanford Junior University),Other,Application,2025-02-04T05:00:00Z,2025,2,2025-02-04T05:00:00Z,,2025-02-04T18:28:05Z,,0,0,090000648691b81b
FDA-2025-E-0359-0001,FDA,FDA-2025-E-0359,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-02-04T05:00:00Z,2025,2,2025-02-04T05:00:00Z,,2025-02-04T18:27:59Z,,0,0,090000648691b819